Epsilon M&A Deal Report - Huvepharma
Transaction Multiples for the Valuation of Private Companies
Citi Venture Capital International (CVCI) / Huvepharma
No EMAT :
38507
Announced Date :
27/09/2010
Type :
Acquisition of Minority Stake
Deal Value :
Yes
Acquirer :
Citi Venture Capital International (CVCI)
Target :
Huvepharma
Country :
Bulgaria
Sector of activity :
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Pharmaceuticals
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Veterinary Pharmaceuticals
Business Description :
Huvepharma AD, along with its subsidiaries, develops, manufactures, and markets human and animal health products . > Offers medicated food additives, such as anticoccidials and anti-infectives and...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
|
|
||||
| Current |
Rating :
**
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Pharmaceuticals » = 131
- Number of EMAT Reports / sub-sector « Veterinary Pharmaceuticals » = 34
| Date | Acquirer | Target | Country | Multiples | See details |
| 06/05/2011 | Allied Healthcare Group | Biju | England | * | 38495 |
| 24/03/2010 | Private Group led by Sovereign Capital | Rehabworks | England | ** | 38488 |
Source: Epsilon Research / EMAT
